Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond

Biomarkers are important tools in medicines development and clinical practice. Besides their use in clinical trials, such as for enrichment of patients, monitoring safety or response to treatment, biomarkers are a cornerstone of precision medicine. The European Medicines Agency (EMA) emphasised the...

Full description

Bibliographic Details
Main Authors: Natalie M. Hendrikse, Jordi Llinares Garcia, Thorsten Vetter, Anthony J. Humphreys, Falk Ehmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.878942/full